Clinical trials
Recruiting Polymyositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| National Institute of Environmental Health Sciences (NIEHS) | 2 |
| Pfizer | 2 |
| Fate Therapeutics | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Myositis International Health & Research Collaborative Alliance Foundation | 1 |
| NYU Langone Health | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 16 |
| Polymyositis | 16 |
| Myositis | 9 |
| Lupus Erythematosus, Systemic | 7 |
| Arthritis, Rheumatoid | 5 |
| Scleroderma, Systemic | 4 |
| Scleroderma, Diffuse | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Arthritis, Psoriatic | 2 |
| Autoimmune Diseases | 2 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.